EMA’s Regulatory Science to 2025 Strategy

EMA’s Regulatory Science to 2025 Strategy

The European Medicine Agency (EMA) is launching a six-month public consultation on its draft ‘ Regulatory Science to 2025’ strategy  for a six-month public consultation. This  sixty-page document proposes the plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines. The strategy will help shape the vision for the next EU Medicines Agencies Network Strategy (2020–2025). It seeks to offer informed guidance on modern medicines development, facilitate the optimisation of regulatory science and critically assess the benefits and risks of innovative therapies and diagnostics based on new technologies.  The five key goals of the strategy include:
catalysing the integration of science and technology in medicine development;
•  driving collaborative evidence generation – improving the scientific quality of evaluations;
advancing patient-centred access to medicines in partnership with healthcare systems (for human medicines only);
• addressing emerging health threats;
enabling and leveraging research and innovation in regulatory science.
Stakeholders are invited to send their comments via an online  questionnaire  by 30 June 2019. They Stakeholders are encouraged to join the discussion on Twitter using the following hashtag: #RegScience2025.